Premium
Primary lung cancer. A controlled study of preoperative and postoperative levels of circulating immune complexes
Author(s) -
Bukh A.,
Aguado M. T.,
Kimose H.H.,
Mouritzen C.,
Møller N. P. H.
Publication year - 1988
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19880515)61:10<2033::aid-cncr2820611018>3.0.co;2-r
Subject(s) - medicine , lung cancer , immune system , lung cancer surgery , lymph node , lung , cancer , oncology , gastroenterology , immunology
Three complement‐dependent and one rheumatoid factor‐dependent immune complex assays were used to analyze the sera taken before surgery from 70 unselected and previously untreated lung cancer patients, from 30 of them after surgery, and from 31 healthy controls. Plasma levels of complement split product C3d were also analyzed. The levels of circulating immune complexes (cIC) and C3d were essentially the same in samples taken from lung cancer patients before surgery and from healthy controls. By the four immune complex assays, increased levels were found in 0 to 10% of the preoperative lung cancer patients compared to 3% of the healthy controls (not significant). The postsurgical tumor, lymph node, metastasis (pTNM) stage of the lung cancer was not reflected in the levels of cIC or C3d. Paired comparisons of the cIC and C3d levels before and after surgery did not show significant differences. Thus, we found no evidence for the occurrence of cancer‐related cIC in lung cancer patients.